Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM60A Inhibitors

Chemical inhibitors of FAM60A can target and modulate the protein's activity by interfering with various signaling pathways and cellular mechanisms that are essential for its function in chromatin remodeling. For instance, PD173074, an inhibitor of the fibroblast growth factor receptor (FGFR), can suppress the downstream signaling required for the functions of FAM60A. Similarly, Y-27632 can disrupt the organization of the actin cytoskeleton, a structural component vital for the nuclear processes where FAM60A is operational. Inhibiting transforming growth factor-beta (TGF-β) receptors using SB431542 would impede the TGF-β signaling, potentially affecting chromatin dynamics and, consequently, the activity of FAM60A. LDN-193189, with its potent inhibition of the BMP pathway, can alter chromatin states and gene expression patterns, leading to the functional suppression of FAM60A. Additional chemical inhibitors work by targeting different aspects of the chromatin remodeling processes that involve FAM60A. For example, SP600125, which inhibits the c-Jun N-terminal kinase (JNK), can interfere with signaling pathways that overlap with those governing chromatin architecture and hence FAM60A's role. U0126, a MEK inhibitor, can indirectly affect FAM60A by inhibiting the MAPK/ERK pathway, which is integral to cell cycle control and gene expression. PI3K/AKT/mTOR signaling, critical for gene expression and chromatin remodeling, can be suppressed by LY294002, which would also impact FAM60A's function. Rapamycin, by inhibiting mTOR, affects cellular growth and gene expression processes that are essential for FAM60A's role in chromatin remodeling. Trichostatin A, as a histone deacetylase inhibitor, can alter the chromatin landscape and affect FAM60A's activity. SGC-CBP30 suppresses the acetylation of histones, potentially restricting FAM60A's regulatory role in chromatin remodeling. Lastly, ICG-001 and ZM447439 disrupt the Wnt/β-catenin signaling and Aurora kinase activity, respectively, both of which are critical to maintaining chromosomal architecture and gene expression patterns that FAM60A is known to influence.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

As an FGFR inhibitor, PD173074 can inhibit the fibroblast growth factor receptor pathway, which is known to be involved in the chromatin remodeling complex that FAM60A is a part of. Inhibition of FGFR would suppress the downstream signaling required for the functioning of the complex, thereby inhibiting FAM60A activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

This compound is a ROCK inhibitor, and ROCK has been implicated in numerous cellular functions including organization of the actin cytoskeleton which is essential for the nuclear architecture where FAM60A operates. Inhibition of ROCK could impair the structural integrity necessary for FAM60A to properly function within the chromatin remodeling complexes.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

By selectively inhibiting the TGF-β receptor, SB431542 can impede the TGF-β signaling pathway. TGF-β signaling is known to regulate a wide range of cellular processes including those that are related to the chromatin structure and function, therefore, inhibition could indirectly hamper FAM60A's role in chromatin remodeling.

4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline

1062368-24-4sc-476297
5 mg
$240.00
(0)

This compound is a potent BMP pathway inhibitor, which influences the chromatin state and gene expression. As FAM60A is implicated in gene regulation via chromatin remodeling, LDN-193189 can inhibit the signaling necessary for FAM60A to exert its function on chromatin.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), SP600125 could disrupt the JNK signaling that may intersect with pathways governing chromatin remodeling and the cellular functions that FAM60A is involved in, leading to an inhibition of FAM60A activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

A MEK inhibitor such as U0126 can inhibit the MAPK/ERK pathway, which is involved in cell cycle control and gene expression regulation. This could indirectly inhibit the function of FAM60A within its chromatin remodeling context, as these pathways are interconnected.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a PI3K inhibitor, LY294002 can suppress the PI3K/AKT/mTOR signaling pathway, which has downstream effects on chromatin remodeling and gene expression where FAM60A plays a role, thereby functionally inhibiting FAM60A.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibiting mTOR with Rapamycin can lead to alterations in cellular growth and gene expression processes that are essential for the proper function of chromatin remodeling complexes involving FAM60A, thus inhibiting its activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This is a histone deacetylase inhibitor that can change the chromatin state, thus potentially inhibiting the function of FAM60A by altering the chromatin landscape it acts upon.

SGC-CBP30

1613695-14-9sc-473871
sc-473871A
5 mg
10 mg
$178.00
$338.00
(0)

As a CREBBP/EP300 inhibitor, SGC-CBP30 can suppress the acetylation of histones, a modification that FAM60A is implicated in regulating within chromatin remodeling complexes, thereby inhibiting FAM60A's functional role.